Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO).

Full DD Report for AVEO

You must become a subscriber to view this report.


Recent News from (NASDAQ: AVEO)

Rounds Report: Solid Biosciences Garnered Big Profits While Stellar FDA Due Diligence To Help Nektar
I constantly see people rise in life who are not the smartest, sometimes not even the most diligent, but they are learning machines. They go to bed every night a little wiser than they were when they got up and boy does that help, particularly when you have a long run ahead of you. - Charlie...
Source: SeekingAlpha
Date: May, 13 2018 02:37
3 Things In Biotech, May 9: New AML Therapy Imminent? AVEO Hedges, Rockwell Boosts Iron
Note: Subscribers to Avisol Capital Partners Total Pharma Tracker got an early look at this publication. Try for free today and see what we're talking about! Here is some more information if you're curious . Welcome to another edition of "3 Things In Biotech You Should Learn Today," a...
Source: SeekingAlpha
Date: May, 10 2018 08:00
Factors of Influence in 2018, Key Indicators and Opportunity within F.N.B., Comcast, IZEA, AVEO Pharmaceuticals, Matador Resources, and TEGNA - New Research Emphasizes Economic Growth
NEW YORK, May 09, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of F.N.B. Corporation (NYSE:FNB), Comcast Corporation (NASDAQ:CMCSA), IZEA In...
Source: GlobeNewswire
Date: May, 09 2018 07:40
Premarket Losers as of 9:05 am (5/8/2018)
ARLZ   -26%  on terminating U.S. operations. More news on: Aralez Pharmaceuticals Inc., Nevro, Nobilis Health Corp., Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: May, 08 2018 09:19
AVEO Pharmaceuticals misses by $0.01, misses on revenue
AVEO Pharmaceuticals (NASDAQ: AVEO ): Q1 EPS of -$0.08 misses by $0.01 . Revenue of $1.03M (-59.3% Y/Y) misses by $0.62M . Shares -1.21% PM. Press Release More news on: AVEO Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news,
Source: SeekingAlpha
Date: May, 08 2018 07:02
AVEO Reports First Quarter 2018 Financial Results and Provides Business Update
AVEO Oncology (NASDAQ:AVEO) today reported financial results for the first quarter ended March 31, 2018 and provided a business update. “We continue to work toward reporting topline results from our Phase 3 TIVO-3 Study, which we now anticipate will occur in the third quarter of 2...
Source: Business Wire
Date: May, 08 2018 07:00
Daily Insider Ratings Round Up 4/10/18: AVEO, IFF, OPK, ICTSF, DXLG, NEWM, HCAP, CONN
InsiderInsights' Daily Round Up articles rate the "significance" of the top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the significance of an insider transaction, however, and there are many more "Signif...
Source: SeekingAlpha
Date: April, 12 2018 09:42
AVEO Pharmaceuticals (AVEO) Presents At H. C. Wainwright Global Life Sciences Conference - Slideshow
The following slide deck was published by AVEO Pharmaceuticals, Inc. in conjunction with this Read more ...
Source: SeekingAlpha
Date: April, 11 2018 12:59
Premarket Gainers as of 9:05 am (04/11/2018)
VHC +23%  on Apple (NASDAQ: AAPL ) patent victory . More news on: VirnetX Holding Corporation, Apple Inc., SemiLEDs Corporation, Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: April, 11 2018 09:21
Q4 Biotech Catalyst Watchlist: Phase 3 Clinical Trials
By Slingshot Insights intern Samuel Jordan We have a full slate of exciting Phase 3 data releases for Q2 2018. This article will focus on four that we think are going to be major catalysts for the companies involved. The Phase 3 data addressed in this article come from trials for Esperio...
Source: SeekingAlpha
Date: April, 09 2018 15:35

 


About AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO)

Logo for AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO)

Not available

 

Contact Information

 

 

Current Share Structure

  • Market Cap: $345,904,341 - 03/20/2018
  • Issue and Outstanding: 118,867,471 - 03/08/2018

 


Recent Filings from (NASDAQ: AVEO)

Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 08 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 08 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 08 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 08 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 27 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: April, 27 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 27 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: April, 27 2018
Filing Type: CT ORDERFiling Source: edgar
Filing Date: April, 26 2018
Filing Type: CT ORDERFiling Source: edgar
Filing Date: April, 26 2018

 

 


Daily Technical Chart for (NASDAQ: AVEO)

Daily Technical Chart for (NASDAQ: AVEO)


Stay tuned for daily updates and more on (NASDAQ: AVEO)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: AVEO)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

Monsta Trader
@MonstaTrader

 

 


Disclaimer: Monsta Trader publishes reports providing information on selected companies. Monsta Trader is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. Monsta Trader accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in AVEO is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. Monsta Trader has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. Monsta Trader does not own any shares of AVEO and does not buy, sell, or trade any shares of AVEO. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by Monsta Trader. All rights reserved. Our Full Disclaimer: http://monstatrader.com/disclaimer/